Empresa

Immatics

Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics. We are only accepting digital applications via the application form of each position. For general inquiries on recruiting topics, please write a message to [email protected] for German recruiting topics or [email protected] for US recruiting topics.